1. Home
  2. SJT vs PRQR Comparison

SJT vs PRQR Comparison

Compare SJT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SJT
  • PRQR
  • Stock Information
  • Founded
  • SJT 1980
  • PRQR 2012
  • Country
  • SJT United States
  • PRQR Netherlands
  • Employees
  • SJT N/A
  • PRQR N/A
  • Industry
  • SJT Oil & Gas Production
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SJT Energy
  • PRQR Health Care
  • Exchange
  • SJT Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • SJT 180.8M
  • PRQR 153.5M
  • IPO Year
  • SJT N/A
  • PRQR 2014
  • Fundamental
  • Price
  • SJT $3.88
  • PRQR $3.96
  • Analyst Decision
  • SJT
  • PRQR Strong Buy
  • Analyst Count
  • SJT 0
  • PRQR 4
  • Target Price
  • SJT N/A
  • PRQR $7.13
  • AVG Volume (30 Days)
  • SJT 160.0K
  • PRQR 1.4M
  • Earning Date
  • SJT 11-22-2024
  • PRQR 11-07-2024
  • Dividend Yield
  • SJT 8.74%
  • PRQR N/A
  • EPS Growth
  • SJT N/A
  • PRQR N/A
  • EPS
  • SJT 0.27
  • PRQR N/A
  • Revenue
  • SJT $15,352,944.00
  • PRQR $20,506,357.00
  • Revenue This Year
  • SJT N/A
  • PRQR $298.83
  • Revenue Next Year
  • SJT N/A
  • PRQR N/A
  • P/E Ratio
  • SJT $14.67
  • PRQR N/A
  • Revenue Growth
  • SJT N/A
  • PRQR 306.68
  • 52 Week Low
  • SJT $3.21
  • PRQR $1.18
  • 52 Week High
  • SJT $7.43
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • SJT 46.56
  • PRQR 66.35
  • Support Level
  • SJT $3.93
  • PRQR $3.50
  • Resistance Level
  • SJT $4.08
  • PRQR $4.10
  • Average True Range (ATR)
  • SJT 0.15
  • PRQR 0.28
  • MACD
  • SJT -0.02
  • PRQR -0.02
  • Stochastic Oscillator
  • SJT 26.92
  • PRQR 72.53

About SJT San Juan Basin Royalty Trust

San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Share on Social Networks: